---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-186640"
form_type: "8-K"
ticker: "SVRA"
cik: "0001160308"
company_name: "Savara Inc"
filed_at: "2023-07-13T23:59:59+00:00"
generated_at: "2026-06-13T08:36:45.263600+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Savara prices $80M underwritten offering of common stock and pre-funded warrants at $3.00/share

## Summary
- Offering of 21M common shares at $3.00/share and 5.67M pre-funded warrants at $2.999/warrant for $80M gross proceeds.
- Expected close July 17, 2023; Jefferies and Piper Sandler are joint book-runners.
- New investors include TCGX, Frazier Life Sciences, Janus Henderson; existing investors Bain, NEA, Adage, Venrock participating.
- Securities offered under effective shelf registration statement (File No. 333-257709).
- Proceeds to fund clinical development and working capital (implied for clinical-stage rare respiratory disease company).

## SEC filing metadata
- accession: 0001193125-23-186640
- form_type: 8-K
- ticker: SVRA
- cik: 0001160308
- company_name: Savara Inc
- filed_at: 2023-07-13T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1160308/000119312523186640/0001193125-23-186640-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1160308/000119312523186640/d513110d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-186640
- JSON: https://secwatch.observer/filing/0001193125-23-186640.json
- Plain text: https://secwatch.observer/filing/0001193125-23-186640.txt

## Key facts
- Material Agreements
  Savara Inc entered into Underwriting Agreement with Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters named therein (effective 2023-07-12).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters named therein
  - Effective: 2023-07-12
  source text: On July 12, 2023, Savara Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters named therein (the “Underwriters”), pursuant to which the Company agreed to issue and sell (i) an aggregate of 21,000,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and (ii) pre-funded warrants to purchase an aggregate of 5,666,667 shares of Common Stock with an exercise price of $0.001 per share (the “Pre-Funded Warrants”), to the Underwriters in an underwritten offering (the “Offering”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1160308/000119312523186640/0001193125-23-186640-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.